zacks.com / Page 8

Palantir's new military deal has boosted its future growth prospects. Is it the ideal time to invest, or should we wait for a better opportunity?

BABA's aggressive AI strategy, expanding cloud infrastructure, and strategic focus on core e-commerce businesses position it for exceptional returns in 2025.

Both NVIDIA and Advanced Micro Devices are benefiting from the AI boom. Which chip stock is a better buy for investors in a challenging macro backdrop?

Since April 2nd, the Dow is -7.65%, the S&P 500 -6.71%, the Nasdaq -6.19% and the small-cap Russell 2000 -8.62%.

MMC's first-quarter results benefit on the back of strong international operations and the Mercer business, partly offset by increased compensation and benefits expense.

Westamerica (WABC) delivered earnings and revenue surprises of 6.42% and 0.28%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Bristol Myers is looking to turn its business around, banking on the strong uptake of new drugs. However, the 2025 outlook is not bright and we recommend investors to wait and watch for now.

According to Petrobras, the Arabia I jack-up rig has arrived in Brazil on April 13, 2025, and is on its way to the Guaricema field to commence well decommissioning tasks.

KEY's first-quarter results top estimates on higher NII & non-interest income alongside lower expenses. However, weak asset quality is a woe.

FHN's Q1 earnings benefit from a marginal rise in NII, and a fall in expenses and provisions. However, declining loan and deposit balances are headwinds.